Molecular epidemiology of West Nile Virus in humans.
After the introduction of West Nile Virus into the United States of America in 1999 followed by annual WNV epidemics during the mosquito seasons and spreading of the virus from the East (New York; 1999) to the West of the U.S. (California; 2003/2004) there appeared the question of whether a similar scenario could happen in Europe, too. To be able to answer this question the German Ministry of Health decided to investigate the prevalence and incidence of WNV infections in German blood donors. First a test algorithm was established taking into account the high level of cross-reactivity between different flavivirus infections in serological test systems. AntiWNV-suspicious specimens were further investigated for their neutralisation capacity and by an antiWNV confirmation assay developed in-house. As a preliminary result of our studies a very low prevalence of WNV infections in healthy German blood donors was measured. Development of highly specific test systems is necessary for accurate and reliable differential diagnosis of flavivirus infections.
Pfleiderer
C
C
Paul-Ehrlich-Institut, Division of Virology, Langen, Germany.
König
C
C
Chudy
M
M
Schmidt
M
M
Roth
W K
WK
Nübling
C M
CM
D000914:Antibodies, Viral / Q000097:blood; D001317:Austria / Q000453:epidemiology; D001782:Blood Donors; D005858:Germany / Q000453:epidemiology; D006801:Humans; D017720:Molecular Epidemiology; D014901:West Nile Fever / Q000453:epidemiology* / Q000821:virology*; D014902:West Nile virus / Q000235:genetics* / Q000302:isolation & purification*
D000914:Antibodies, Viral